Antibodies to tubulin and microtubule-associated proteins - A study in diabetes mellitus, systemic lupus erythematosus, and rheumatoid arthritis

N. A. Cullum, J. W. Coleman, I. F. Casson, W. G. McLean

    Research output: Contribution to journalArticlepeer-review

    Abstract

    We report the results of a study of serum antibodies to proteins of the nerve cytoskeleton in patients with Type I and Type II diabetes mellitus, both with and without clinical signs of diabetic neuropathy. In contrast to previous reports, elevated levels of antibody to tubulin or glycated tubulin were not associated with either diabetes or diabetes with related neuropathy. Similarly, clinical evidence of neuropathy in patients with diabetes did not relate to increased levels of antibody to native or glycated microtubule-associated proteins (MAPs). The levels of antibody to MAPs and glycated MAPs were higher in control subjects over the age of 45 years compared with younger control subjects. Increased levels of antibody to tubulin and glycated tubulin were found in the sera of patients with systemic lupus erythematosus, but not rheumatoid arthritis. © 1991 Humana Press.
    Original languageEnglish
    Pages (from-to)159-172
    Number of pages13
    JournalMolecular and chemical neuropathology
    Volume15
    Issue number2
    DOIs
    Publication statusPublished - Oct 1991

    Keywords

    • autoantibodies
    • diabetes
    • diabetic complications
    • glycation
    • microtubule-associated proteins
    • Microtubules
    • neuronal antibodies
    • neuropathies
    • rheumatoid arthritis
    • SLE
    • tubulin

    Fingerprint

    Dive into the research topics of 'Antibodies to tubulin and microtubule-associated proteins - A study in diabetes mellitus, systemic lupus erythematosus, and rheumatoid arthritis'. Together they form a unique fingerprint.

    Cite this